Flagship explainer
What drives Bionano Genomics, Inc.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| −$26.4M | FY2025 |
| |
| Income before tax | −$26.3M | FY2025 |
|
| Operating income | −$33.3M | FY2025 |
|
| $28.5M | FY2025 |
| |
| Ending assets | $73.6M | FY2025 |
|
| Beginning assets | $76.7M | FY2024 |
|
| $44.4M | FY2025 |
| |
| $35.4M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001411690-26-000007